FIRST TRUST ADVISORS LP

Position in CLDX — Celldex Therapeutics, Inc.

CIK 1125816 Wheaton, IL

Position in CLDX

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$5,160,357

+$2,988,489 QoQ

Shares Held

138,682

+102.5% QoQ

Ownership

0.177%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#70

of 252 holders

Holding Since

Dec 2021

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

FIRST TRUST ADVISORS LP holds $2,824,813,122 across 97 Biotechnology names. CLDX ranks #65 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	547,132	$341,158,687
2	INCY	Incyte Corp	1,587,996	$180,015,226
3	CORT	Corcept Therapeutics Inc	1,829,545	$159,078,937
4	VRTX	Vertex Pharmaceuticals Inc / Ma	289,179	$143,643,884
5	EXEL	Exelixis, Inc.	2,543,353	$138,383,836
6	ALNY	Alnylam Pharmaceuticals, Inc.	421,534	$126,894,380
7	KRYS	Krystal Biotech, Inc.	324,900	$120,755,583
8	AXSM	Axsome Therapeutics, Inc.	482,061	$117,994,070

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$5,160,357	138,682	+102.5%	Shares	Sole	2026-08-11
2026-03-31	$2,171,868	68,470	+78.7%	Shares	Sole	2026-05-13
2025-12-31	$1,040,581	38,313	+7.8%	Shares	Sole	2026-02-13
2025-09-30	$919,186	35,531	+93.4%	Shares	Sole	2025-11-12
2024-12-31	$464,260	18,372	-50.9%	Shares	Sole	2025-02-13
2024-09-30	$1,272,687	37,443	-51.8%	Shares	Sole	2024-11-13
2024-06-30	$2,877,009	77,736	+11.2%	Shares	Sole	2024-08-13
2024-03-31	$2,933,493	69,895	+504.5%	Shares	Sole	2024-05-13
2023-12-31	$458,588	11,563	-78.2%	Shares	Sole	2024-02-13
2023-03-31	$1,909,530	53,072	+410.4%	Shares	Sole	2023-05-15
2022-09-30	$292,315	10,399	+4.4%	Shares	Sole	2022-11-14
2022-06-30	$268,494	9,959	-81.1%	Shares	Sole	2022-08-12
2022-03-31	$1,797,448	52,773	-48.2%	Shares	Sole	2022-05-13
2021-12-31	$3,932,895	101,783	—	Shares	Sole	2022-02-08
No filing history on record for this holder in this stock.